NeuPulse Wearable Stimulation Device
Tourette Syndrome (motor and vocal tics)
Pre-commercialActive
Key Facts
About NeuPulse
NeuPulse is pioneering a wearable neuromodulation device for Tourette Syndrome, representing a significant shift from pharmacological interventions. The technology, based on median nerve stimulation, has shown promising results in UK clinical trials, with participants reporting substantial reductions in tic severity. The company is targeting a commercial launch in Great Britain in 2026, followed by international expansion, positioning itself to address a significant unmet need in the neurostimulation market. Its business model combines a device sale with a recurring software subscription.
View full company profile